Conference abstract · 5 Oct 2020
Conference abstract
Guidelines proposal for nanomaterials hemocompatibility
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanosciences and nanotechnologies are in constant evolution. Development of new therapeutic and diagnostic agents using nanotechnologies for reach their pharmaceutical target require the knowledge of biocompatibility of nanoparticles with the blood compounds. The aim of this study is the evaluation of the biocompatibility of manufactured nanoparticles (NPs) (carbon based, silver, silicon dioxide, copper oxide and silicon carbide nanoparticles) on erythrocytes integrity, on platelets aggregation and on coagulation cascade. Hemostasis is the ensemble of physiological phenomena which prevent and lead to stop bleeding; it maintains the vascular integrity. A dysfunction of the hemostasis can lead to slow down or even to completely stop the circulation of the blood. It is therefore primordial to know what NPs can have an effect on coagulation. Various techniques assessing activation and aggregation of the platelets or the impact of NPs on coagulation cascade were investigated. An approach in transmission and in scanning electronic microscopy was also accomplished. The Impact-R? with scanning electronic microscopy support and the calibration thrombin generation tests were the reference method to investigate the potential impact of NPs on platelet function and the procoagulant activity of NPs, respectively. Based on the results obtained, we suggest guidelines for testing NP hemocompatibility which responds to a request of scientific community due to lack of recommendations for the evaluation of nanomaterial hemocompatibility.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 22 Feb 2019
A PROPOSAL FOR LIGHTING DESIGN GUIDELINES - CASE OF EDUCATIONAL BUILDINGS
Conference abstract · 2018
Revisiting the increased prevalence of clozapine induced cardiotoxicity in New Zealand and Australia and a proposal for a pragmatic cardiotoxicity monitoring guideline
Conference abstract · 2018
A proposal for expansion of current guidelines for the genotoxicity testing of new drugs: The case of BIA 10-2474, a novel fatty acid amide hydrolase inhibitor
Editorial · 3 Mar 2016
Foetal Alcohol Spectrum Disorder (FASD) diagnostic guidelines: a neuropsychological diagnostic criteria review proposal
More from this journal
The newest in Journal of Nanomedicine & Nanotechnology.
Article · 16 Feb 2026
Evaluation of In vitro Anticancer Activity of Poly Herbal Extract (Vitis vinifera, Nigella sativa and Curcurbita pepo Seeds)
Article · 21 Oct 2025
Green Synthesis of Chromium(III) Oxide Nanoparticles and their Evaluation against Skin Infections
Article · 19 Jun 2025
Potential of Bhasma as Nanomedicine for Disease Management: A Synopsis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Julie Laloy”

